维普中文期刊产品整合服务
22篇 您的检索式:作者名="Polyxeni"
    题名 作者 年代 出处 被引量
1Circulating biomarkers of hepatocellular carcinoma response after locoregional treatments: New insights显示文摘Hepatocellular cancer is the 5th most common cancer in the world and the third cause of death by malignant disease. Locoregional therapies are the most usual treatment of choice for patients with early or intermediate stage of disease. The main diagnostictools for the detection of recurrence are the radiological techniques such as 4-phase computed tomography or dynamic contrast enhanced magnetic resonance imaging. However, in order to achieve best evaluation of treatment outcome and recurrence rates, there is a great need for the identification of specific and easily measured circulating biomarkers. The aim of this review is to analyze the existing data considering the prognostic significance of changes of serum diagnostic markers such as alpha-fetoprotein, des-gamma-carboxy prothrombin, alpha-fetoprotein-L3, angiogenetic factors(vascular endothelial growth factor, hypoxia inducible factor-1a) and immune parameters before and after radiofrequency ablation or transarterial chemoembolization.Maria Tampaki Polyxeni P Doumba Melanie Deutsch John Koskinas 2015World Journal of Hepatology2015,7,14:2
2Negativation of type 1 diabetes‐associated autoantibodies to glutamic acid decarboxylase and insulin in children treated with oral calcitriol (口服骨化三醇治疗维持儿童1型糖尿病相关的谷氨酸脱羧酶与胰岛素自身抗体阴性)显示文摘Dimitrios T. Papadimitriou Chrisanthi Marakaki Andreas Fretzayas Polyxeni Nicolaidou Anastasios Papadimitriou 2013Journal of Diabetes2013,,3:2
3Mutlifunctional ATRP initiators:Synthesis of four-arm star homopolymers of methyl methacrylate and graft copolymers of polystyrene and poly(t-butyl methacrylate)显示文摘Polyxeni M Stergios P Nikos H 2001J Polym Sci Part A:Polym Chem2001,39,:1
4Surgical treatment for large hepatocellular carcinoma: does size matter?显示文摘Georgios Tsoulfas Alexandros Mekras Polyxeni Agorastou Dimitrios Kiskinis 2012ANZ Journal of Surgery . 2012 (7‐8)2012,,7:1
5Genomic variation in the MAP3K5 gene is associated with &bgr;-thalassemia disease severity and hydroxyurea treatment efficacy显示文摘Christina Tafrali Arsinoi Paizi Joseph Borg Milena Radmilovic Marina Bartsakoulia Emily Giannopoulou Olga Giannakopoulou Maja Stojiljkovic-Petrovic Branka Zukic Konstantinos Poulas Eleana F Stavrou Polyxeni Lambropoulou Alexandra Kourakli Alexander E Feli 2013Pharmacogenomics2013,,5:1
6Circulating CD40+and CD86+B cell subsets demonstrate opposing associations with risk of stroke显示文摘Polyxeni T Mantani Irena Ljungcrant 2014Arterioscler Thromb Vasc Biol2014,34,1:1
7Mutlifunctional ATRP initiators:Synthesis of four-arm star homopolymers of methyl methacrylate and graft copolymers of polystyrene and poly(t-butyl methacrylate) 显示文摘Polyxeni M Stergios P Nikos H 2001J Polym Sci Polym Chem2001,39,5:1
8Effects of Interleukin-6 on Depression Risk in Dialysis Patients显示文摘Sonikian Makrouhi Metaxaki Polyxeni Papavasileiou Dimitrios Boufidou Fotini Nikolaou Chrysoula Vlassopoulos Dimosthenis Vlahakos Demetrios V 2010American Journal of Nephrology2010,,4:1
9Recruitment of Actin Modifiers to TrkA Endosomes Governs Retrograde NGF Signaling and Survival显示文摘Anthony W. Harrington Coryse St. Hillaire Larry S. Zweifel Natalia O. Glebova Polyxeni Philippidou Simon Halegoua David D. Ginty 2011Cell2011,,3:1
10Laparoscopic vs open donor nephrectomy:Lessons learnt from single academic center experience显示文摘AIM To compare laparoscopic and open living donor nephrectomy,based on the results from a single center during a decade.METHODS This is a retrospective review of all living donor nephrectomies performed at the Massachusetts General Hospital,Harvard Medical School,Boston,between 1/1998- 12/2009. Overall there were 490 living donors,with 279 undergoing laparoscopic living donor nephrectomy(LLDN) and 211 undergoing open donor nephrectomy(OLDN). Demographic data,operating room time,the effect of the learning curve,the number of conversions from laparoscopic to open surgery,donor preoperative glomerular filtration rate and creatinine(Cr),donor and recipient postoperative Cr,delayed graft function and donor complications were analyzed. Statistical analysis was performed.RESULTS Overall there was no statistically significant difference between the LLDN and the OLDN groups regarding operating time,donor preoperative renal function,donor and recipient postoperative kidney function,delayed graft function or the incidence of major complications. When the last 100 laparoscopic cases were analyzed,there was a statistically significant difference regarding operating time in favor of the LLDN,pointing out the importance of the learning curve. Furthermore,another significant difference between the two groups was the decreased length of stay for the LLDN(2.87 d for LLDN vs 3.6 d for OLDN).CONCLUSION Recognizing the importance of the learning curve,this paper provides evidence that LLDN has a safety profile comparable to OLDN and decreased length of stay for the donor.Georgios Tsoulfas Polyxeni Agorastou Dicken SC Ko Martin Hertl Nahel Elias AB Cosimi Tatsuo Kawai 2017World Journal of Nephrology2017,6,1:1
11Thyroid Dysfunction and Autoantibodies in Early Pregnancy Are Associated with Increased Risk of Gestational Diabetes and Adverse Birth Outcomes显示文摘Polyxeni Karakosta Dimitris Alegakis Vaggelis Georgiou Theano Roumeliotaki Eleni Fthenou Maria Vassilaki Dimitrios Boumpas Elias Castanas Manolis Kogevinas Leda Chatzi 2012The Journal of Clinical Endocrinology & Metabolism2012,,12:1
12Blue rubber bleb nevus syndrome with simultaneous neurological and skeletal involvement显示文摘Meropi S. Tzoufi Polyxeni Sixlimiri Iliada Nakou Maria I. Argyropoulou Constantinos J. Stefanidis Antigone Siamopoulou-Mavridou 0,,:1
13THE RELATIONSHIP BETWEEN LISTENING AND READING COMPREHENSION OF DIFFERENT TYPES OF TEXT AT INCREASING GRADE LEVELS显示文摘Irene-Anna N. Diakidoy Polyxeni Stylianou Christina Karefillidou Panayiota Papageorgiou 2004Reading Psychology2004,,1:1
14Effects of interleukin-6 on depression risk in dialysis patients 显示文摘Makrouhi S Polyxeni M Dimitrios P 2010Am J Nephrol2010,31,4:1
15Mother to child transmission of hepatitis C virus: Rate of infection and risk factors显示文摘Vassiliki Syriopoulou Georgia Nikolopoulou George L. Daikos Maria Theodoridou Ioanna Pavlopoulou Polyxeni Nicolaidou Nina Manolaki 2005Scandinavian Journal of Infectious Diseases2005,,5:1
16Rapid enzymatic chemiluminescent assay of glucose by means of a hybrid flow-injection / sequential-injection method显示文摘Polyxeni Panoutsou Anastasios Economou 2005Talanta2005,67,3:1
17Regional Tourism Authorities and Tourism Policy Monitoring: The Case of Greek RTOs显示文摘Polyxeni Moira Dimitrios Mylonopoulos 2012China-USA Business Review2012,11,5:1
18Quantitative relationship of stress Tc-99m sestamibi lung uptake with resting Tl-201 lung uptake and with indices of left ventricular dysfunction and coronary artery disease显示文摘Gaurav M Patel Thomas H Hauser J.Anthony Parker Duane S Pinto Gregory P Sanders Franz C Aepfelbacher Polyxeni Koutkia Peter G Danias 2004Journal of Nuclear Cardiology2004,,4:1
19Approaching Differentiated Instruction via the Attitudes and the Opinions of Greek Primary School Teachers: An Empirical Investigation显示文摘loannis Fykaris Polyxeni MiLsi 2012Journal of Sociology Study2012,2,12:0
20Anti-angiogenic drugs in cancer therapeutics:a review of the latest preclinical and clinical studies of anti-angiogenic agents with anticancer potential显示文摘Cancer is a group of diseases with significant morbidity and mortality.In cancer cells,where energy requirements are exceptionally high,angiogenesis,which is the sprouting of new blood vessels from pre-existing ones,is an important process for tumour survival and progression.Hence,extensive research in recent years focuses on the discovery of new anticancer drugs that target angiogenesis.Several methodologies have been developed preclinically,including the inhibition of pro-angiogenic factors and their receptors via micromolecular agents or monoclonal antibodies and the inhibition of other compensatory pathways beyond the traditional angiogenic ones.The purpose of the literature review is to present new anticancer drugs that target the process of angiogenesis and have been under preclinical or clinical investigation during the last five years.Many new anticancer drugs targeting angiogenesis are identified in the literature.The results of the in vitro and in vivo evaluation of these drugs show that,apart from inhibiting angiogenesis,they also affect cancer cell proliferation and tumour growth.Recent clinical studies show that these drugs increase the overall or disease-free survival of patients,even those with persistent,chemotherapy-resistant and metastatic types of cancer,although treatment-related side effects are not uncommon.Drugs that target the process of angiogenesis are likely to be the future of anticancer therapy,especially in cases where more traditional treatments do not produce the desired results and where combination regimens of anti-angiogenic agents with standard chemotherapeutics increase patient survival.Polyxeni Vafopoulou Malamati Kourti 2022Journal of Cancer Metastasis and Treatment2022,8,1:0
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费